Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00513955. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04115631. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00377052. IPD Sharing: NO. Countries: 1. Publications: 1.
Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00005074. IPD Sharing: NO. Countries: 1. Publications: 1.
Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment
ClinicalTrials.gov study NCT02341781. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00641095. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00787969. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03877055. IPD Sharing: YES. Countries: 1. Publications: 0.
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma
ClinicalTrials.gov study NCT06482684. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02858258. IPD Sharing: NO. Countries: 5. Publications: 2.
Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00621452. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Disease Registry of Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03816683. IPD Sharing: YES. Countries: 1. Publications: 16.
CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04718883. IPD Sharing: NO. Countries: 1. Publications: 1.
Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00234026. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT00786851. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of PD 0332991 Plus Bortezomib in Patients With Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01111188. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03523975. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
ClinicalTrials.gov study NCT03267433. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00070447. IPD Sharing: Not stated. Countries: 5. Publications: 0.
HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma
ClinicalTrials.gov study NCT00144092. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.